ANRO - Alto Neuroscience Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Alto Neuroscience Inc.
IPO Date: February 2, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $942.99M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.65 | 6.15%
Avg Daily Range (30 D): $0.73 | 2.38%
Avg Daily Range (90 D): $0.90 | 3.39%
Institutional Daily Volume
Avg Daily Volume: .42M
Avg Daily Volume (30 D): .38M
Avg Daily Volume (90 D): .4M
Trade Size
Avg Trade Size (Sh.): 93
Avg Trade Size (Sh.) (30 D): 48
Avg Trade Size (Sh.) (90 D): 53
Institutional Trades
Total Institutional Trades: 275
Avg Institutional Trade: $1.99M
Avg Institutional Trade (30 D): $3.09M
Avg Institutional Trade (90 D): $2.66M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.94M
Avg Closing Trade (30 D): $4.08M
Avg Closing Trade (90 D): $3.39M
Avg Closing Volume: 139.51K
 
News
Feb 26, 2026 @ 5:07 PM
Psychedelic Medicine Advances: Here Are Five Compa...
Source: Prnewswire
Oct 7, 2025 @ 10:05 PM
ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi...
Source: Bragar Eagel & Squire, P.C.
Sep 19, 2025 @ 8:49 PM
Investors who lost money on Alto Neuroscience, Inc...
Source: Levi & Korsinsky, Llp
Sep 19, 2025 @ 1:50 PM
ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA...
Source: Rosen Law Firm
Sep 18, 2025 @ 8:00 PM
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.65 $-.8
Diluted EPS $-.65 $-.8
Revenue $M $M
Gross Profit
Net Income / Loss $-27.64M $-26.24M
Operating Income / Loss $-29.13M $-27.14M
Cost of Revenue
Net Cash Flow $-20.03M $87.28M
PE Ratio